- Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.N Engl J Med. 2017; 376: 1047-1053
FDA Warns About Stem Cell Therapies. 2019; https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies. Accessed May 30, 2021.
Internet hawkers of stem cell therapies raising red flags. Ophthalmology Times; 2020. https://www.ophthalmologytimes.com/view/internet-hawkers-of-stem-cell-therapies-raising-red-flags.
- Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.Ophthalmology. 2019; 126: 1350-1355
Publication stageIn Press Journal Pre-Proof
Financial Support: Bascom Palmer Eye Institute received funding from the NIH Core Grant P30EY014801, Department of Defense Grant #W81XWH-13-1-0048, and a Research to Prevent Blindness Unrestricted Grant. The sponsors or funding organizations had no role in the design or conduct of this research.
Conflict of Interest: NAY (Advisor: Alimera Sciences, Alcon, Novartis, Genentech), AEK (Consultant/Advisor (Alimera Sciences, Allergan, Bausch + Lomb, Genentech, Novartis, Recens Medical, Regeneron, Spark Therapeutics; Speaker: Optos, Spark Therapeutics; Grant Funding: Genentech, Spark Therapeutics), JS (Consultant: Alcon, Allergan, Dorc, Genentech, Regeneron),
Short Title: Intravitreal Injection Patient Knowledge of Stem Cell Therapy
Meeting Presentation: Presented at The Association for Research in Vision and Ophthalmology (ARVO), 2021